CHOICE Allergen Immunotherapy study
CHOICE study coordinators are looking for clinicians to join them in an international multi-centre academic project, which looks at factors that drive the prescription of allergen immunotherapy in real-life clinical settings.
Study title: CHOICE = “Criteria Used by Health Professionals on the Selection of Allergen Immunotherapy in Real Clinical Practice: an international E-survey”.
National CHOICE study coordinators: Prof Connie Katelaris AM, Head of Immunology, Campbelltown Hospital, Dr Narinder Kaur, Clinical Immunologist and Allergist, Dr Margaret Li, Allergy and Immunology Fellow, SCHN.
To be a part of this project, clinicians are required to complete a quick 10-minute web-based survey about current practice when prescribing allergen immunotherapy and also a short questionnaire for each patient that you are prospectively planning to commence on allergen immunotherapy.
All data will be anonymous and stored securely. For further information, please see the PDF information sheet for clinicians Clinician Information Sheet672.98 KB
This news item was issued on 17 January 2023 by Jill Smith, CEO of the Australasian Society of Clinical Immunology and Allergy (ASCIA). ASCIA is the peak professional body for clinical immunology and allergy in Australia and New Zealand.